The formulation and an expanded indication for Tivicay tablets are currently under review in Europe The US Food and Drug Administration has approved the first-ever dispersible tablet formulation of ...
Deborah Waterhouse, CEO of ViiV Healthcare, said: “ I am delighted that our innovative approach to science has enabled us to achieve FDA approval of the first-ever dispersible tablet formulation of ...
TRIUMEQ PD is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in children. TRIUMEQ PD contains the prescription medicines Abacavir, ...
A new sweetened, cherry-flavoured dispersible antimalarial tablet is as effective as the crushed, currently used variety, which needs to be crushed before administration to small children, resulting ...
Akums Drugs & Pharmaceuticals Ltd. has announced the launch of the world’s first Lasmiditan dispersible tablets, marking an important step forward in the treatment of acute migraine. The DCGI-approved ...
The CHMP recommendation is based on data from studies including a phase 2 trial. ((Otsuka)) Otsuka is on course to further expand use of its treatment for pulmonary multidrug resistant tuberculosis ...
Children living with HIV have to take multiple different antiretroviral (ARV) pills or syrups twice a day, while most adults in South Africa have been offered one pill once a day regimen for around a ...
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114. Cefpodoxime proxetil (CFPD PRXL) is a third-generation cephalosporin antibiotic with ...
ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi B.V. (Shionogi) as shareholders, has announced that the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results